[FATE] QoQ Quarter Result on 30-Jun-2017 [#Q2]

Stock
[FATE] Fate Therapeutics, Inc.
Announcement Date
14-Aug-2017
Financial Year
2017
Quarter
30-Jun-2017 [#Q2]
Profit Trend
QoQ- 4.75%
YoY- -14.71%
Quarter Report
FATE's Result
FATE's Financial Summary
View:
Show?
Quarter Result
31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 CAGR
Revenue 1,026 1,027 1,026 1,026 1,027 1,027 1,026 0.00%
PBT -14,135 -12,497 -10,684 -9,645 -10,126 -7,940 -8,737 37.85%
Tax 331 -131 378 137 111 -160 37 331.51%
NP -14,135 -12,497 -10,684 -9,645 -10,126 -7,940 -8,737 37.85%
Tax Rate - - - - - - - -
Total Cost 15,161 13,524 11,710 10,671 11,153 8,967 9,763 34.13%
Ratio Analysis
31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 CAGR
NP Margin -1,377.68 -1,216.85 -1,041.33 -940.06 -985.98 -773.13 -851.56 37.85%
Per Share
31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 CAGR
EPS -0.27 -0.29 -0.26 -0.23 -0.24 -0.21 -0.27 0.00%
EPS Diluted -0.27 -0.29 -0.26 -0.23 -0.24 -0.21 -0.27 0.00%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.